(SJT) San Juan Basin Royalty Trust - Overview
Stock: Oil, Natural Gas, Royalty Interest
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 35.9% |
| Relative Tail Risk | -4.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.03 |
| Alpha | 33.90 |
| Character TTM | |
|---|---|
| Beta | 0.551 |
| Beta Downside | 0.586 |
| Drawdowns 3y | |
|---|---|
| Max DD | 68.40% |
| CAGR/Max DD | -0.19 |
Description: SJT San Juan Basin Royalty Trust December 31, 2025
San Juan Basin Royalty Trust (NYSE:SJT) is an express trust headquartered in Dallas, Texas, that holds a 75% net overriding royalty interest in Southland’s oil and natural-gas assets across 119,000 net-producing acres in the San Juan Basin of northwestern New Mexico (San Juan, Rio Arriba, and Sandoval Counties). The trust’s portfolio consists of a mix of working interests, royalty interests, overriding royalty interests, and other contractual rights, providing exposure to both crude oil and natural-gas production.
Key metrics that investors watch include the trust’s average monthly distribution per unit (≈ $0.55 USD as of Q3 2024) and its cost-per-barrel breakeven, which recent SEC filings place around $30 USD for oil and $2.50 USD for natural gas-well below current market prices. The San Juan Basin’s production is heavily influenced by regional drilling activity, the U.S. Henry Hub natural-gas price, and the West Texas Intermediate (WTI) crude benchmark; a 10% rise in WTI typically lifts SJT’s net cash flow by roughly 4% given its production mix.
For a deeper dive into SJT’s valuation dynamics and how its royalty structure compares to peers, a quick look at ValueRay’s analytical snapshot can provide useful context.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -5.44m TTM > 0 and > 6% of Revenue |
| FCF/TA: 333.6 > 0.02 and ΔFCF/TA 33.4k > 1.0 |
| NWC/Revenue: -997.6% < 20% (prev 1.46%; Δ -999.0% < -1%) |
| CFO/TA 333.6 > 3% & CFO 9.73m > Net Income -5.44m |
| Net Debt (-29.2k) to EBITDA (592.4k): -0.05 < 3 |
| Current Ratio: 0.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.6m) vs 12m ago 0.0% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 1.29% > 50% (prev 954.9%; Δ -953.6% > 0%) |
| Interest Coverage Ratio: -0.02 > 6 (EBITDA TTM 592.4k / Interest Expense TTM 5.33m) |
What is the price of SJT shares?
Over the past week, the price has changed by -6.94%, over one month by +0.36%, over three months by -6.17% and over the past year by +48.94%.
Is SJT a buy, sell or hold?
What are the forecasts/targets for the SJT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.5 | 264.1% |
| Analysts Target Price | 20.5 | 264.1% |
| ValueRay Target Price | 5.7 | 0.9% |
SJT Fundamental Data Overview February 05, 2026
P/B = 111.893
Revenue TTM = 24.6k USD
EBIT TTM = -111.3k USD
EBITDA TTM = 592.4k USD
Long Term Debt = unknown (none)
Short Term Debt = 274.1k USD (from shortTermDebt, last quarter)
Debt = unknown
Net Debt = -29.2k USD (from netDebt column, last quarter)
Enterprise Value = 268.9m USD (268.9m + (null Debt) - CCE 29.2k)
Interest Coverage Ratio = -0.02 (Ebit TTM -111.3k / Interest Expense TTM 5.33m)
EV/FCF = 27.64x (Enterprise Value 268.9m / FCF TTM 9.73m)
FCF Yield = 3.62% (FCF TTM 9.73m / Enterprise Value 268.9m)
FCF Margin = 39.6k% (FCF TTM 9.73m / Revenue TTM 24.6k)
Net Margin = -22.2k% (Net Income TTM -5.44m / Revenue TTM 24.6k)
Gross Margin = unknown ((Revenue TTM 24.6k - Cost of Revenue TTM 2.42m) / Revenue TTM)
Tobins Q-Ratio = 9222 (set to none) (Enterprise Value 268.9m / Total Assets 29.2k)
Interest Expense / Debt = unknown (Interest Expense 12.5k / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -87.9k (EBIT -111.3k * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.11 (Total Current Assets 29.2k / Total Current Liabilities 274.1k)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.05 (Net Debt -29.2k / EBITDA 592.4k)
Debt / FCF = -0.00 (Net Debt -29.2k / FCF TTM 9.73m)
Total Stockholder Equity = 2.57m (last 4 quarters mean from totalStockholderEquity)
RoA = -285.9% (out of range, set to none)
RoE = -211.8% (Net Income TTM -5.44m / Total Stockholder Equity 2.57m)
RoCE = 45.44% (negative capital employed) (EBIT -111.3k / Capital Employed (Total Assets 29.2k - Current Liab 274.1k))
RoIC = -40.26% (negative operating profit) (NOPAT -87.9k / Invested Capital 218.5k)
WACC = 7.95% (E(268.9m)/V(268.9m) * Re(7.95%) + (debt-free company))
Discount Rate = 7.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 70.45% ; FCFF base≈5.86m ; Y1≈3.85m ; Y5≈1.76m
Fair Price DCF = 0.74 (EV 34.6m - Net Debt -29.2k = Equity 34.7m / Shares 46.6m; r=7.95% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -73.37 | EPS CAGR: -61.31% | SUE: N/A | # QB: 0
Revenue Correlation: -86.58 | Revenue CAGR: -94.11% | SUE: N/A | # QB: 0